Systematic review of immunohistochemical biomarkers to identify prognostic subgroups of patients with pancreatic cancer

LMO2 Is a Novel Predictive Marker for a Better Prognosis in Pancreatic Cancer

(2015) Kohei Nakata et al.   NEOPLASIA

Positive Expression of L1-CAM is Associated with Perineural Invasion and Poor Outcome in Pancreatic Ductal Adenocarcinoma

(2010) Qi-Wen Ben et al.   ANNALS OF SURGICAL ONCOLOGY

Insulin-like growth factor 2 mRNA binding protein 3 (IGF2BP3) overexpression in pancreatic ductal adenocarcinoma correlates with poor survival

(2010) David F Schaeffer et al.   BMC CANCER

BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received

(2010) S-J Dawson et al.   BRITISH JOURNAL OF CANCER

Estimates of cancer incidence and mortality in Europe in 2008

(2010) J. Ferlay et al.   EUROPEAN JOURNAL OF CANCER

Expression of L1CAM, COX-2, EGFR, c-KIT and Her2/neu in anaplastic pancreatic cancer: putative therapeutic targets?

(2010) Frank Bergmann et al.   HISTOPATHOLOGY

Cellular Histone Modification Patterns Predict Prognosis and Treatment Response in Resectable Pancreatic Adenocarcinoma: Results From RTOG 9704

(2010) Ananya Manuyakorn et al.   JOURNAL OF CLINICAL ONCOLOGY

Biomarkers: The Useful and the Not So Useful—An Assessment of Molecular Prognostic Markers for Cutaneous Melanoma

(2010) Bonnie E. Gould Rothberg et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Vascular endothelial growth factor targeted therapy in the perioperative setting: implications for patient care

(2010) Debashish Bose et al.   LANCET ONCOLOGY

Pancreatic Cancer

(2010) Manuel Hidalgo   NEW ENGLAND JOURNAL OF MEDICINE

Differential cell cycle and proliferation marker expression in ductal pancreatic adenocarcinoma and pancreatic intraepithelial neoplasia (PanIN)

(2010) Eva Karamitopoulou et al.   PATHOLOGY

Identification of MicroRNA-21 as a Biomarker for Chemoresistance and Clinical Outcome Following Adjuvant Therapy in Resectable Pancreatic Cancer

(2010) Jin-Hyeok Hwang et al.   PLoS One

CD74 Is a Novel Prognostic Factor for Patients with Pancreatic Cancer Receiving Multimodal Therapy

(2009) Shigenori Nagata et al.   ANNALS OF SURGICAL ONCOLOGY

Low-Level Expression of Smad7 Correlates with Lymph Node Metastasis and Poor Prognosis in Patients with Pancreatic Cancer

(2009) Peng Wang et al.   ANNALS OF SURGICAL ONCOLOGY

RNA interference targeting against S100A4 suppresses cell growth and motility and induces apoptosis in human pancreatic cancer cells

(2009) Takahiro Tabata et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

High expression of CXCR4 may predict poor survival in resected pancreatic adenocarcinoma

(2009) R Maréchal et al.   BRITISH JOURNAL OF CANCER

Increased expression of ALCAM/CD166 in pancreatic cancer is an independent prognostic marker for poor survival and early tumour relapse

(2009) C Kahlert et al.   BRITISH JOURNAL OF CANCER

Cancer Statistics, 2009

(2009) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Associations between Selected Biomarkers and Prognosis in a Population-Based Pancreatic Cancer Tissue Microarray

(2009) M. Takikita et al.   CANCER RESEARCH

Dkk-3 expression in the tumor endothelium: A novel prognostic marker of pancreatic adenocarcinomas

(2009) Dominic Fong et al.   CANCER SCIENCE

HER2 overexpression correlates with survival after curative resection of pancreatic cancer

(2009) Masahiro Komoto et al.   CANCER SCIENCE

XAF1 as a prognostic biomarker and therapeutic target in pancreatic cancer

(2009) Jia Huang et al.   CANCER SCIENCE

Molecular markers associated with lymph node metastasis in pancreatic ductal adenocarcinoma by genome-wide expression profiling

(2009) Seiko Hirono et al.   CANCER SCIENCE

Human Equilibrative Nucleoside Transporter 1 and Human Concentrative Nucleoside Transporter 3 Predict Survival after Adjuvant Gemcitabine Therapy in Resected Pancreatic Adenocarcinoma

(2009) R. Marechal et al.   CLINICAL CANCER RESEARCH

Synuclein-  Is Closely Involved in Perineural Invasion and Distant Metastasis in Mouse Models and Is a Novel Prognostic Factor in Pancreatic Cancer

(2009) T. Hibi et al.   CLINICAL CANCER RESEARCH

Prognostic signature for pancreatic cancer: are we close?

(2009) Jen Jen Yeh   Future Oncology

Prognostic value of metastin expression in human pancreatic cancer

(2009) Kazuyuki Nagai et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Tissue Biomarkers for Prognosis in Cutaneous Melanoma: A Systematic Review and Meta-analysis

(2009) Bonnie E. Gould Rothberg et al.   JNCI-Journal of the National Cancer Institute

Molecular predictive and prognostic markers in non-small-cell lung cancer

(2009) Linda E Coate et al.   LANCET ONCOLOGY

Clinicopathological Correlations of Cyclooxygenase-2, MDM2, and p53 Expressions in Surgically Resectable Pancreatic Invasive Ductal Adenocarcinoma

(2009) Marketa Hermanova et al.   PANCREAS

Actinin-4 Expression in Primary and Metastasized Pancreatic Ductal Adenocarcinoma

(2009) Thilo Welsch et al.   PANCREAS

Expression of the GLUT1 glucose transporter and p53 in carcinomas of the pancreatobiliary tract

(2009) Ji-Youn Sung et al.   PATHOLOGY RESEARCH AND PRACTICE

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

(2009) David Moher et al.   PLOS MEDICINE

Structural Biology of the Tumor Suppressor p53

(2008) Andreas C. Joerger et al.   Annual Review of Biochemistry

High expression of TROP2 correlates with poor prognosis in pancreatic cancer

(2008) D Fong et al.   BRITISH JOURNAL OF CANCER

CD133 expression is correlated with lymph node metastasis and vascular endothelial growth factor-C expression in pancreatic cancer

(2008) S Maeda et al.   BRITISH JOURNAL OF CANCER

High mobility group AT‐hook 1 (HMGA1) is an independent prognostic factor and novel therapeutic target in pancreatic adenocarcinoma

(2008) Siong‐Seng Liau et al.   CANCER

Sp1, a New Biomarker That Identifies a Subset of Aggressive Pancreatic Ductal Adenocarcinoma

(2008) N. Y. Jiang et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Expression of MAP4K4 Is Associated with Worse Prognosis in Patients with Stage II Pancreatic Ductal Adenocarcinoma

(2008) J. J. Liang et al.   CLINICAL CANCER RESEARCH

Human Equilibrative Nucleoside Transporter 1 Levels Predict Response to Gemcitabine in Patients With Pancreatic Cancer

(2008) James J. Farrell et al.   GASTROENTEROLOGY

Loss of trimethylation at lysine 27 of histone H3 is a predictor of poor outcome in breast, ovarian, and pancreatic cancers

(2008) Yongkun Wei et al.   MOLECULAR CARCINOGENESIS

Chemokine Receptor CCR7 Expression Correlates with Lymph Node Metastasis in Pancreatic Cancer

(2008) Bunzo Nakata et al.   ONCOLOGY

Prognostic significance of S100A4 and vascular endothelial growth factor expression in pancreatic cancer

(2008) Kai-Xing Ai et al.   WORLD JOURNAL OF GASTROENTEROLOGY